glp-1 mood improvement Receptor Agonists in Disorders: A Psychiatric Perspective GLP-1 trials show mood improvement – Added Value to GLP-1 Receptor

Combined metabolic activators improve cognitive functions in Alzheimers disease patients: a randomised, double-blinded, placebo-controlled phase-II trial

These formulations are not branded drugs but prescription-strength compounds prepared by licensed pharmacies, offering access without prior authorization delays

Tirzepatide treatment was administered at three final doses (5, 10, 15 mg per week), with treatment initiated at 2.5 mg and the dose escalated every 4 weeks

For those unfamiliar, direct-to-consumer (DTC) telehealth connects patients with licensed providers virtually, offering consultations and prescriptions without the need for traditional in-person visits

American Society for Metabolic and Bariatric Surgery (ASMBS)

However, this result relied entirely on unadjusted data, was driven largely by a single large cohort, and lacked detail on specific malformation subtypes, limiting how much can be concluded from it